dominant negative Cdk5 construct, nuclei appeared condensed and fragmented. On the other hand, a reduction of RasGRF1 levels through p35/Cdk5 overexpression also leads to nuclear condensation in neurons. These data show that phosphorylation of RasGRF1 by Cdk5 tightly regulates its levels, which is essential for proper cellular organization.
. It is significant that Cdk5 plays a regulatory role since it is involved in 'crosstalk' with other kinase and signal transduction cascades. Cdk5 participates in 'cross-talk' with the extracellular signal-regulated kinase (Erk) pathway [18] , calcium/ calmodulin-dependent protein kinase (CaMK) [19] , cJun N-terminal kinase (JNK3) [20] pathways and, more recently, RasGRF2-mediated Rac signaling [21] . Our previous findings showed that p35/Cdk5 phosphorylation of the Ras guanine nucleotide exchange factor 2 (RasGRF2) resulted in regulation of MAP1b distribution in neurons through modulation of Rac-mediated Erk1/2 activity [21] . RasGRF1 and RasGRF2 are guanine nucleotide exchange factors (GEFs) that display a high degree of homology to each other, where RasGRF2 is ubiquitously expressed while RasGRF1 is mainly expressed in the nervous system. Thus, we wanted to investigate whether RasGRF1 was also a substrate of Cdk5 and what the biological function of this phosphorylation was in neurons. We found that RasGRF1 was phosphorylated by Cdk5. This phosphorylation on serine 731 regulated RasGRF1 steady state levels and tight regulation of Ras-GRF1 levels was critical for proper nuclear organization in both mitotic and post-mitotic cells. When RasGRF1 levels are elevated through the loss of Cdk5 activity or by RasGRF1 overexpression, neuronal nuclei appeared condensed and fragmented. When RasGRF1 levels are reduced by increased Cdk5 activity, the nuclei are also condensed and disorganized thus suggesting that nuclear organization was controlled by RasGRF1 levels which, in turn, was controlled by Cdk5 phosphorylation.
Materials and Methods

Antibodies and Reagents
Polyclonal anti-RasGRF1 antibody (Santa Cruz Biotechnology, Santa Cruz, Calif., USA) were used at 1: 1,000 for immunocytochemistry in transfected cells, 1: 500 for Western blotting, 1: 100 for endogenous protein detection by immunocytochemistry and at 1: 50 for immunoprecipitations. Anti-p35 (C19) and Cdk5 (J3 and C8) antibodies (Santa Cruz Biotechnology) were used at 1: 1,000 dilutions to detect transfected proteins and at 1: 200 to detect endogenous proteins. Monoclonal anti-Xpress (Invitrogen, Carlsbad, Calif., USA) and T7 (Novagen, San Diego, Calif., USA) epitope tag antibodies were used at 1: 500 and 1: 1,000 dilutions in Western blotting studies, respectively. Phospho-serine/threonine-proline (MPM-2) antibody was obtained from Upstate (Chicago, Ill., USA). Horseradish peroxidase-conjugated secondary antibodies (Amersham-Pharmacia, Piscataway, N.J., USA) were used at 1: 2,000 dilutions. Anti-mouse/rabbit Oregon green, Texas red and Alexa Fluor 633 fluorescent-conjugated antibodies (Invitrogen, Molecular Probes, Eugene, Oreg., USA) were used at 1: 400 dilutions. EGTA was purchased from Sigma (St. Louis, Mo., USA). Calpain I ( -calpain) and II (m-calpain) inhibitors (N-acetylLeu-Leu-norleucinal and N-acetyl-Leu-Leu-methioninal, respectively) were obtained from Roche Biochemicals (Indianapolis, Ind., USA) and were described previously [22, 23] .
Plasmids p35, wild-type and dominant-negative Cdk5 cDNAs in pcDNA3.1C vector were cloned into pcDNA3.1C and described previously [21] . Rat RasGRF1 was cloned into pcDNA3 vector (Invitrogen). p35, Cdk5 and DNCdk5 were subcloned into the lentiviral vector packaging system and cortical neurons were transduced as previously described [24] . Wild-type Ras was subcloned into the pCEFL vector.
Mammalian Cell Culture and Transfection
CHO and COS cells were grown in F12/HAM and Advanced-DMEM, respectively (Invitrogen), containing 10% (v/v) fetal bovine serum supplemented with 2 m M glutamine, 100 U/ml penicillin and 100 g/ml streptomycin. CHO and COS-7 cells were transfected using lipofectamine (Invitrogen) essentially according to the manufacturer's instructions. For immunofluorescence studies, COS cells were cultured in 6-well plates (BD Biosciences, Palo Alto, Calif., USA) on glass coverslips. Transfected CHO cells were treated with 2 m M EGTA, 100 M calpain inhibitor I and 50 M calpain inhibitor II for 16 h. Total cell lysates were prepared for Western blotting as described previously [25] . Rat and mouse embryonic cortical neurons were prepared using the papain disassociation technique described previously [24] and cultured for 3-7 days in culture (DIC) prior to analyses. Transfections of embryonic mouse and rat cortical neurons were performed after 3 DIC using lipofectamine 2,000 (Invitrogen).
Co-Immunoprecipitation Studies
CHO cells were transfected using lipofectamine (Invitrogen) according to the manufacturer's instructions with empty pcDNA3.1, RasGRF1, RasGRF1+p35 and RasGRF1+p35+Cdk5. Cells were harvested 24 h after transfection and lysed in ice-cold immunoprecipitation (IP) lysis buffer containing 50 m M Tris-Cl pH 7.5, 150 m M NaCl, 1% Triton-X-100, 1 m M EDTA, 5 g/ml leupeptin, 2 g/ml aprotinin, 5 g/ml pepstatin, 1 m M PMSF, 10 M sodium fluoride and 1 M sodium orthovanadate. Cells were incubated on ice for 30 min, vortexed briefly and then cleared by centrifugation at 14,000 rpm for 30 min. Lysates were precleared for 1 h at 4 ° C and RasGRF1 was immunoprecipitated using anti-RasGRF1 antibody for 2 h at 4 ° C with constant rocking. Immunoglobulin was pulled down using protein A Sepharose beads (Sigma) overnight at 4 ° C. Immunoprecipitates were washed three times with IP lysis buffer. Samples were prepared for SDS-PAGE analysis by addition of SDS sample buffer and heated at 95 ° C for 5 min. To examine endogenous RasGRF1 staining, 5-DIC cortical neurons were used. Primary antibodies were then visualized using either goat anti-mouse or goat anti-rabbit Igs coupled to Oregon green or Texas red (Molecular Probes), diluted in blocking solution for 1 h at room temperature and nuclei were counter-stained using DAPI (Sigma). Coverslips were washed in PBS between incubations and mounted in Gel/Mount TM (Biomeda, Hayward, Calif., USA). Fluorescence images were acquired using a 63X oil-immersion objective on a Zeiss LSM510 confocal microscope and managed with Adobe Photoshop.
Immunocytochemical Analyses
Immunohistochemical Analyses
Immunohistochemistry of mouse brain sections was performed as described previously [26] . Briefly, 3-month-old female DLB7 mice were deeply anaesthetised with pentobarbitone and transcardially perfused with PBS followed by a freshly made and filtered solution of 4% paraformaldehyde in PBS (pH 7.4). Brains were subsequently removed and post-fixed for 6 h at 4 ° C in the same fixative prior to cryoprotection at 4 ° C in a solution of 30% sucrose in Tris-buffered saline (TBS: 40 m M Tris, 0.7% NaCl in 10 m M phosphate buffer, pH 7.8) containing 0.05% sodium azide prior to freezing on dry ice and storage at -80 ° C. 30-m frozen coronal sections were collected in TBS-azide buffer at 4 ° C prior to immunohistochemical staining for RasGRF1 and p35. The optimal concentrations of primary (rabbit anti-p35 and RasGRF1, 1: 200 and 1: 100, respectively) were determined by performing a checkerboard titration. Sections were rinsed in TBS and blocked for 20 min with 15% normal goat serum (NGS) prior to incubation in a solution of anti-RasGRF1 and p35 antisera in TBS-T (TBS containing 0.3% Triton X-100)/10% NGS for 16 h at 4 ° C. Sections were subsequently rinsed with TBS, incubated for 2 h in secondary antiserum (goat anti-rabbit IgG-Tx Red, Molecular Probes), diluted 1: 400 in TBS-T/10% NGS. Images were captured on a Zeiss LSM 510 confocal microscope. Experiments were repeated three times and identical results were obtained from all three experiments and representative sections were used for illustration.
In vitro Site-Directed Mutagenesis
RasGRF1 serine-alanine 731 phosphorylation mutant (RasGRF1 Ser-Ala731 ) was produced using the Quikchange XL sitedirected mutagenesis kit (Stratagene, La Jolla, Calif., USA) according to the manufacturer's instructions using wild-type Ras-GRF1/pCEFL as the template. Putative mutants were sequenced to confirm the mutation of serine 731 to alanine 731 using primers 50 bases upstream and downstream of the site.
In vitro and in vivo Phosphorylation of RasGRF1 by p35/Cdk5
CHO cells were transfected with RasGRF1 and Ras-GRF1 . RasGRF1 was immunoprecipitated using the polyclonal anti-RasGRF1 antibody. Immunoprecipitates were incubated with GST, GST-Cdk5+GST-p35 [27] and ␥ 32 P-ATP with and without roscovitine, separated by SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were exposed to the STORM phosphoimager followed by immunodetection of Ras-GRF1 using Western blotting. To confirm Cdk5 activity, histone H1 was used as a substrate in identical reactions described above. Samples were resolved by SDS-PAGE and gels were Coomassie stained and destained then dried and subjected to autoradiography. RasGRF1 was immunoprecipitated from wild-type and p35 knockout mouse brain lysates, separated by SDS-PAGE and subjected to Western blotting using anti-RasGRF1 and anti-phospho-serine antibodies to detect total and phosphorylated Ras-GRF1, respectively.
Ras and Rac Activity Assays
Ras assays were performed using the EZDetect Ras Activation Kit according to the manufacturer's instructions (Pierce, Rockford, Ill., USA). CHO cells were transfected with empty vector+Ras, RasGRF1+Ras, RasGRF1+Ras+p35+Cdk5, RasGRF1+Ras+p35+dominant negative Cdk5 and Ras-GRF1 Ser-Ala731 +p35+Cdk5. After 24 h, cells were harvested using ice-cold IP lysis buffer containing 10 m M MgCl 2 . Active Ras levels were assayed by incubation with GST-c-Raf on glutathione Sepharose beads for 1 h. Rac activity assays were performed as described previously with the use of the EZDetect Rac activity kit using GST-PAK1-BD as bait (Pierce). Bound active Ras and Rac were washed three times in lysis buffer and eluted from the GST beads using 2 ! SDS sample buffer containing 5% ␤ -mercaptoethanol (Sigma) and boiling for 5 min. Samples were separated using 4-20% SDS-PAGE and subjected to Western blotting using the monoclonal anti-Ras and Rac antibodies provided in the kit. Ras and Rac activity were determined by detecting Ras and Rac eluted from GST-c-Raf/PAK1-BD beads and normalizing this signal to that of total Ras and Rac found in lysates.
Results
p35 Interacts with RasGRF1
In a previous study from our laboratory, we reported that RasGRF2 interacted with and was phosphorylated by p35/Cdk5. We wanted to know whether the homologous protein RasGRF1 also interacted with p35/Cdk5 and used co-immunoprecipitation assays to investigate this. In CHO cells that were co-transfected with Ras-GRF1 with and without p35/Cdk5, it was found that p35 co-immunoprecipitated with RasGRF1 in these studies ( fig. 1 A) . This is consistent with our previous findings, and of others, that showed p35 directs substrates to Cdk5 [5, 25, 28] . Interestingly, we also found that upon cotransfection of RasGRF1+p35+Cdk5, RasGRF1 steady state levels were consistently reduced, a result expanded later in the study. To determine whether p35 and Ras-GRF1 did indeed exist in similar cellular compartments and to further confirm the co-immunoprecipitation data, we transfected COS-7 cells with p35+RasGRF1 and p35+Cdk5+RasGRF1. Both p35 and RasGRF1 existed in identical cytoplasmic compartments in transfected COS-7 cells and co-localized with each other ( fig. 1 Bd, h). To confirm the interaction in brain lysates, p35 was immunoprecipitated from rat brain lysates using the monoclonal anti-p35 antibody and immunodetected using C19 polyclonal antibody ( fig 
Cdk5 Phosphorylates RasGRF1 on Serine 731
Our previous study showed that p35/Cdk5 phosphorylated RasGRF2 on serine 737 and mediated Rac signaling and Erk1/2 activity [21] . The corresponding residue in RasGRF1 is serine 731, where the amino acid sequence is TSS * PVRRR, an ideal consensus Cdk5 phosphorylation site. To determine whether RasGRF1 is a substrate of Cdk5, RasGRF1 wild-type and phospho-deficient mutant RasGRF1
Ser-Ala731 were immunoprecipitated from transfected CHO cells and used in in vitro kinase assays using recombinantly expressed and purified GST and GST-p35/Cdk5 in the absence and presence of the potent Cdk5 inhibitor roscovitine. RasGRF1 was phosphorylated when incubated with GST-p35/Cdk5 but not when in- To confirm the in vitro data, we immunoprecipitated RasGRF1 from age-matched wild-type and p35 knockout (p35-/-) mouse brain lysates. The level of serine/threonine-proline phosphorylation of RasGRF1 was decreased in p35-/-lysates compared to wild-type lysates ( fig. 2 D, top panel) . Additionally, the expression of RasGRF1 was increased in p35-/-brain (see below).
Cdk5 Controls RasGRF1 Steady State Levels
It was found that steady state levels of RasGRF1 in p35-/-lysates were elevated compared to wild-type lysates ( fig. 3 A, top panel) while Cdk5 levels were unchanged (data not shown). To confirm that this effect was attributed to Cdk5 activity in neurons, cortical neurons were transduced with lentiviral combinations of empty vector (EV), p35+Cdk5 and p35+dominant-negative Cdk5. The overexpression of p35+Cdk5 caused a reduction in Ras-GRF1 levels compared to EV infected neurons ( fig. 3 B) . The infection of p35+dominant-negative Cdk5 rescued RasGRF1 levels ( fig. 3 B, lane 3) . To identify the precise site that is phosphorylated by Cdk5 to control RasGRF1 levels, CHO cells were co-transfected with RasGRF1, RasGRF1+p35+Cdk5, RasGRF1+p35+ dominant negative Cdk5 and RasGRF1
Ser-Ala731 +p35+Cdk5. The co-transfection of active Cdk5 with wild-type RasGRF1 ( fig. 3 C, lane 2) led to a reduction in RasGRF1 levels compared to Ras-GRF1-only transfected cells ( fig. 3 C, lane 1) . Additionally, the co-transfection of RasGRF1 with p35+dominant negative Cdk5 ( fig. 3 C, lane 3) and the co-transfection of RasGRF1
Ser-Ala731 with p35+Cdk5 ( fig. 3 C, lane 4) rescued the levels of RasGRF1. These data suggested that phosphorylation of RasGRF1 leads to its degradation.
RasGRF1 Is Proteolyzed by m-Calpain upon Cdk5 Phosphorylation
To elucidate the mechanism of RasGRF1 degradation, we treated RasGRF1+p35+Cdk5-transfected cells with the proteosomal inhibitor MG132 and the lysosomal inhibitor ammonium chloride (NH 4 Cl). We found that neither inhibitor could prevent the degradation of RasGRF1. the polyclonal anti-RasGRF1 antibody. Overlay panels show Ras-GRF1 and p35 co-localization in yellow. C p35 was immunoprecipitated from rat brain lysate using monoclonal anti-p35 antibody and p35 and RasGRF1 immunodetected using anti-C19 (top panel) and RasGRF1 (bottom panel) polyclonal antibodies, respectively. + and -refer to the presence or absence of immunoprecipitating antibody, respectively, and rat brain lysate resolved as a marker of the proteins (RB lysate). p35 (indicated by the asterisk) co-immunoprecipitated with RasGRF1. D To determine whether endogenous p35 and RasGRF1 exist in similar compartments in neurons, 5 days in culture (5DIC) cortical neurons were immunostained for the presence of p35 ( a ) and RasGRF1 ( d ), nuclei staining ( b , e ) and overlays are shown in c and f . Both proteins exhibited perikaryal localization in neurons. Scale bar = 50 m. E To determine whether RasGRF1 and p35 were similarly distributed in adult mouse brain, coronal sections were immunostained using polyclonal RasGRF1 ( a , c , e ) and p35 ( b , d , f ) antibodies. RasGRF1 and p35 occupied similar areas in the cortex, hippocampus and cerebellum. -alanine 731 (731) mutant, immunoprecipitated and used as the substrate. Samples were separated by SDS-PAGE and transferred onto nitrocellulose. The autorad (top panel) was obtained prior to RasGRF1 immunodetection using anti-RasGRF1 antibody (bottom panel) where Cdk5/p35 phosphorylated RasGRF1 ( 32 P-RasGRF1) and this was abolished with the serine-alanine 731 mutant (731). C As the positive control for Cdk5/p35 activity, histone H1 was used as a substrate in similar assays. Autorad (top panel) shows the phosphorylated histone H1 ( 32 P-H1) while the corresponding Coomassie-stained gel (bottom panel) shows equal loading of histone H1 (H1). Results shown are a representative autroradiograph of three separate experiments with identical results. D Lysates were prepared from adult wild-type and p35 knockout (p35-/-) mice brain. RasGRF1 was immunoprecipitated and the presence of phospho-RasGRF1 was immunodetected using the phospho-serine/threonine-proline antibody (top panel). The presence of total RasGRF1 was confirmed using the Ras-GRF1 antibody (bottom panel). The phosphorylation was quantified in the bar graph on the right where phospho-serine/threonine-proline-RasGRF1 signal was normalized to total RasGRF1. Results are expressed as 8 SEM of 4 independent experiments. There was an approximate 2.5-fold reduction in phospho-Ras-GRF1 in the Cdk5 knockout compared to wild-type immunoprecipitates. This suggested that degradation of RasGRF1 was not due to proteosomal or lysosomal pathways (data not shown). The other possible mechanism which may be responsible for phosphorylated RasGRF1 degradation was a calciumdependent proteolytic pathway. To evaluate this we treated RasGRF1+p35+Cdk5-transfected CHO cells with the calcium chelator EGTA and found a marked rescue of RasGRF1 levels ( fig. 3 D) . We then tested calpain inhibitors I and II, which are sensitive for -calpain and m-calpain, respectively. Only the m-calpain inhibitor (inhibitor II) was effective in rescuing RasGRF1 levels ( fig. 3 E) .
Cdk5 Regulates RasGRF1 Levels in Neurons
To determine whether RasGRF1 levels are indeed regulated by Cdk5 in vivo, we performed immunocytochemical analyses of mouse embryonic cortical neurons. Cortical neurons from E16.5 wild-type and Cdk5 knockout mice were grown for 3 days in culture (DIC) before immunostaining for RasGRF1. This length of time was chosen since after this time, Cdk5 knockout neurons undergo massive cell death (data not shown, and [20] ). Confocal images from Cdk5 knockout neurons ( fig. 4 Ad-f) contained greater RasGRF1 levels compared to the wildtype neurons ( fig. 4 Aa-c). These data corroborate data shown in figure 3 B. To confirm this, we transfected wildtype Cdk5 into the knockout neurons and found that the Cdk5 knockout neurons containing wild-type Cdk5 (arrowed in fig. 4 B) had reduced RasGRF1 immunostaining compared to surrounding nontransfected neurons. Additionally, nuclear organization of these neurons appeared normal compared to the condensed nuclei of neighboring, nontransfected neurons. To ensure that the levels of RasGRF1 are indeed controlled by Cdk5, we transfected dominant-negative Cdk5 into rat embryonic cortical neurons and found that the transfected neuron, without active Cdk5, exhibited increased RasGRF1 ( fig. 4 C) accompanied with altered nuclear morphology.
Cdk5 Phosphorylation of RasGRF1 Causes Nuclear Disorganization
To examine the effect of increasing or reducing RasGRF1 levels in cells, COS-7 cells were transfected with Ras only, Ras+RasGRF1+p35+Cdk5, Ras+ RasGRF1mut731+p35+Cdk5 and Ras+p35+Cdk5. Overexpression of RasGRF1+Ras altered nuclear organization where nuclei were compacted ( fig. 5 e-h) . The elevation of RasGRF1 levels through the expression of the RasGRF1 Ser-Ala731 also caused similar nuclear changes ( fig. 5 m-p) . The nuclei of Ras-only-and p35+Cdk5+Ras-transfected cells were not disorganized ( fig. 5 a-d and 5 q-t, respectively), thus ruling out any effect attributed to the presence of p35/Cdk5 or Ras.
RasGRF1 Levels Are Essential for Neuronal Nuclear Organization
Cdk5 knockout neurons, after 3 days in culture, exhibit condensed nuclei and start to die after this time (data not shown). RasGRF1 starts to be expressed at 3DIC in cortical neurons and so the question arose whether the loss of Ras-GRF1 regulation through the loss of Cdk5 activity was the cause for the nuclear disorganization in these neurons. Experiments using transfection of dominant-negative Cdk5 into neurons resulted in an increase in RasGRF1 coupled with nuclear condensation (arrowed in fig. 6 Aa-d). Overexpression of p35/Cdk5 in neurons also causes disintegration of neuronal nuclei with a concomitant decrease in RasGRF1 levels in the transfected neuron (arrowed in fig.  6 Be-h). The data suggested that a loss of regulation of Ras-GRF1 levels, either through increases or decreases, is detrimental to neuronal nuclear organization. Since Cdk5 activity is involved in a number of neuronal functions, we needed to narrow down the role of RasGRF1 in controlling nuclear organization. For this, RasGRF1
Ser-Ala731 was overexpressed so that it could not be degraded by Cdk5. In the transfected neuron (arrowed in fig. 6 Ci-k), the build-up of RasGRF1 was clearly evident, as was the fragmentation of the nucleus of that neuron. Similar results were obtained when wild-type RasGRF1 was transfected into neurons suggesting that endogenous p35/Cdk5 activity is insufficient to phosphorylate the elevated levels of RasGRF1 and the resultant over-expression causes similar nuclear changes (arrowed in fig. 6 Dl-n).
Phosphorylation of RasGRF1 by p35/Cdk5 Modulates Ras Signaling and Akt Activation
Since RasGRF1 has been shown to activate Ras and Rac signaling pathways, the downstream effect of Cdk5 phosphorylation on RasGRF1 was investigated. Ras and Rac activity assays were performed using transfected CHO cells since these cells exhibited the highest transfection efficiencies of all cells tested. Ras only transfected cells showed moderately active Ras levels which increased when RasGRF1 was co-transfected with Ras ( fig. 7 A,  lanes 1 and 2) . The active Ras levels were reduced when RasGRF1 was co-transfected with p35+Cdk5+Ras ( fig. 7 A, lane 3) . The presence of dominant-negative Cdk5+p35+RasGRF1 and the phospho-mutant Ras-GRF1 Ser-Ala731 +p35+Cdk5 maintained the levels of active Ras comparable to the assays that contained only wildtype RasGRF1+Ras ( fig. 7 A, lanes 4 and 5) . Ras+RasGRF1; where Ras was detected using Oregon green and RasGRF1 with Texas red ( e-h ). Ras+p35+Cdk5+RasGRF1 ( i-l ) and Ras+p35+Cdk5+RasGRF1mut731 ( m-p ) where p35/Cdk5 were detected using Xpress and Texas red and RasGRF1 with Oregon green. Ras+p35+Cdk5 ( q-t ); where Ras was detected using anti-AU5 epitope antibody and Texas red, while p35/Cdk5 was detected using anti-Xpress epitope tag and Texas red. Overexpression of RasGRF1+Ras altered nuclear organization and the elevation of RasGRF1 levels through the expression of the RasGRF1 Ser-Ala731 also caused the nuclear changes. Scale bar = 50 m. Fig. 6 . Tight regulation of RasGRF1 levels is required for neuronal nuclear organization. A 3 days in culture rat cortical neurons were transfected with DNCdk5 and immunostained for Cdk5 and RasGRF1. Nuclei were stained with DAPI. In the transfected neuron, the RasGRF1 level was increased and its nucleus was condensed compared to the non-transfected neuron. B 3DIC rat cortical neurons were co-transfected with p35 and Cdk5. Transfected neurons were visualized with the T7 epitope tag antibody and nuclei were visualized with DAPI. The overexpression of p35/Cdk5 Phosphorylates RasGRF1 In our previous study with RasGRF2, we found that p35/Cdk5 phosphorylation caused a specific reduction of Rac but not Ras activity. Moreover, Erk1/2 activation was reduced leading to a modulation of MAP1b distribution but not that of tau, MAP2 or actin [21] . Thus, we wanted to determine whether p35/Cdk5 phosphorylation of Ras-GRF1 caused similar specific downstream effects. We found that phosphorylation of RasGRF1 by p35/Cdk5 did not significantly affect Rac activity ( fig. 7 B) . The slight decrease in Rac activity with RasGRF1+p35+Cdk5 is insignificant when normalized to total Rac levels ( fig. 7 B,  lane 3) . Rac activity assays were tested by incubating empty vector transfected lysate with GTP before performing binding and pull-down assay and this exhibited highest levels of Rac activity as expected. However, phosphorylation of RasGRF1 by p35+Cdk5 caused a reduction in phospho-Akt levels ( fig. 7 C, lane 3 Ser-Ala731 mutant with p35/Cdk5 restored the levels of phospho-Akt to that found in the absence of p35/Cdk5. Surprisingly, Erk1/2 activity was unaffected when RasGRF1 was co-transfected with p35+Cdk5 ( fig. 7 D) .
Discussion
RasGRF1 and RasGRF2 are guanine nucleotide exchange factors (GEFs) that display a high degree of homology to each other and both regulate the transition of inactive GDP-bound Ras and Rac to their active GTPbound forms. We previously showed that RasGRF2 was phosphorylated by p35/Cdk5 on serine 737 [21] . The corresponding site in RasGRF1 is serine 731 and we found that p35/Cdk5 associated with and phosphorylated Ras-GRF1 on this site. We consistently found that co-transfection of RasGRF1 with p35/Cdk5 in CHO cells resulted in a decrease in RasGRF1 steady state levels. The overexpression of either the dominant-negative Cdk5 or the phosphodeficient RasGRF1 mutant reversed this effect. Additionally, we found that in vivo levels of RasGRF1 in p35 knockout brain lysates were increased compared to their wild-type littermates. Cortical neurons derived from Cdk5 knockout embryos also contained higher, amounts of RasGRF1 compared to neurons from wildtype embryos. The overexpression of RasGRF1 and its reduction by overexpression of p35/Cdk5 resulted in nuclear condensation in COS-7 cells and cortical neurons. When p35+Cdk5+RasGRF1+Ras were co-transfected into COS-7 cells, nuclei are compacted and this is also seen when RasGRF1 is overexpressed. All four proteins are normally expressed in neurons and perhaps the overexpression of all 4 proteins are required for normal function. However, levels of expression in this system may not accurately mimic a neuronal system and if one is higher, then the system is imbalanced. These data showed that RasGRF1 levels have to be tightly regulated for normal neuronal function and organization. A striking co-incidence was that Cdk5 knockout neurons start to exhibit condensation of nuclei and subsequent death after 3 days in culture. RasGRF1 expression is also apparent in neurons at 3 days in culture (data not shown). Thus, when RasGRF1 levels are deregulated through the absence of Cdk5 activity, neuronal nuclear condensation occurs.
RasGRF1 is also phosphorylated by protein kinase A [29] and by nonreceptor tyrosine kinase ACK1 [30] to modulate Ras activity, introducing the phenomenon of kinase-mediated regulation of RasGRF1 signaling. Previous reports have shown that the phosphorylation by PKA and ACK activate Ras and Rac without affecting Cells were incubated with GST-c-Raf and were washed and then prepared for SDS-PAGE by boiling in 2 ! SDS-sample buffer. Samples were transferred onto nitrocellulose and subjected to Western blotting using anti-Ras antibody. Total Ras levels were immunodetected from lysates. B To detect active Rac, CHO cells were transfected with empty vector (1), RasGRF1 (2), RasGRF1+p35+Cdk5 (3), RasGRF1+p35+dominant-negative Cdk5 (4), RasGRF1mut731+p35+Cdk5 (5), and EV+GTP (6) . Lysates were incubated with GST-PAK1-BD and samples were subjected to SDS-PAGE and Western blotting. Quantification of repeated Rac assays showed that any decrease in Rac activity was insignificant. C To determine the downstream effect of the modulation of RasGRF1-mediated Ras activity by p35/Cdk5, the activity of Akt was investigated. Lysates from CHO cells transfected with empty vector+Ras (1), RasGRF1+Ras (2), RasGRF1+p35+Cdk5+Ras (3), RasGRF1+p35+dominant-negative Cdk5+Ras (4), and RasGRF1mut731+p35+Cdk5+Ras (5) were subjected to SDS-PAGE and Western blotting for phosphoand total Akt levels. D To investigate whether p35/Cdk5 affects Erk1/2 activity, lysates in ( C ) were immunodetected for phospho and total Erk1/2. All data are representative Western blots of 3 separate experiments and quantification is shown in the bar graphs on the right.
RasGRF1 levels [30] [31] [32] . Thus, the phosphorylation of RasGRF1, by various kinases, has very different biological functions. RasGRF1 is localized to the plasma membrane through its pleckstrin homology (PH) domain, although the exact mechanism of this is not fully understood but is thought to involve binding to membrane phospholipids or membrane-associated proteins such as G-protein ␤ ␥ subunits [33] . Interestingly, p35 is also localized to the plasma membrane through a myristoylation sequence found close to its amino-terminal [34] . Additionally, Ras is also localized to the inner leaflet of the plasma membrane which is important for its signaling role and brings it into close proximity with RasGRF1 and p35/Cdk5. Surprisingly, we found that p35/Cdk5 phosphorylation and subsequent reduction of RasGRF1 levels did not affect RasGRF1-mediated Erk1/2 activity contrary to reports from other groups [35, 36] . We can only suggest that in the CHO cell system used in the experiments described, Erk1/2 activity was not controlled by RasGRF1. Indeed, in our previous studies, Erk1/2 activity in this system, was controlled by Ras-GRF2-mediated Rac activation.
In RasGRF1 knockout mice, ischemia-induced CREB activation is reduced and neuronal damage is enhanced [37] . CREB transcription factor is a survival-promoting factor. These findings are corroborated by our findings since in our experiments, the overexpression of p35/ Cdk5 causes a decrease in RasGRF1 levels, a subsequent reduction in Ras activation, a reduction in active Akt (a marker of cell survival) linked to the disintegration of neuronal nuclei. Another report showed both RasGRF1 and RasGRF2 couple N-methyl-D -aspartate glutamate receptors to the activation of the Ras/Erk pathways [36] . Members of the N-methyl-D -aspartate class of glutamate receptors (NMDARs) are critical for development, synaptic transmission, learning and memory. NMDARs are phosphorylated by serine/threonine and tyrosine kinases to regulate its activity and Cdk5 has been shown to phosphorylate the NR2A subunit of NMDA receptors [38] .
Another paradigm where the interaction between RasGRF1 and Cdk5 activity may be of importance is in ␤ cells of the pancreas. RasGRF1 was originally thought to be expressed exclusively in the CNS; however, recent reports have shown that RasGRF1 is expressed and is required for ␤ cell development and glucose homeostasis [39] . RasGRF1 knockout mice exhibit reduced body weight, glucose intolerance and hypoinsulinemia due to a reduction in ␤ cells which are manifestations of preclinical type 2 diabetes [39] . Interestingly, p35/Cdk5 expression and activity has also been found in these pancreatic ␤ cells induced by glucose [40] . These data introduce yet another possible role for p35/Cdk5 and phosphorylation of RasGRF1 may not only be involved in neuronal function, but may also modulate RasGRF1 levels to influence ␤ cell development. This may contribute to normal pancreatic function or the development of type 2 diabetes, areas that require further study.
We propose that tight regulation of RasGRF1 levels is required for proper cellular organization. This hypothesis relies on a homeostasis between Cdk5 activity levels and levels of critical signaling intermediates such as Ras-GRF1 for normal cell function. The tight regulation of RasGRF1 levels is inextricably linked to its control of Ras activation. It is clear that a deletion of RasGRF1 in mice is detrimental to long-term potentiation (LTP) with some dispute over which area in the brain is responsible for this [41, 42] . The elevated levels of RasGRF1 in p35 and Cdk5 knockout mice also seem to play a role in synaptic plasticity. The loss of Cdk5 activity affects the phosphorylation of a number of synaptic proteins and has been shown to affect LTP [38, 43] . Therefore, RasGRF1 levels and activity could be responsible for synaptic abnormalities in these paradigms. We also believe that regulation of Ras signaling mediated by RasGRF1 is regulated by local Ca 2+ concentrations ( fig. 8 ) . Additionally, we believe that recognition of substrates by enzymes is crucial to function. Ca 2+ is an intracellular signal which is responsible for vast array of cellular processes. An increase in intracellular calcium can be generated from sources inside as well as outside the cell. The endoplasmic reticulum network is an internal source where Ca 2+ release is facilitated under the control of the channels. External Ca 2+ enters the cell through voltage-operated channels, store-operated channels (upon depletion of internal Ca 2+ levels) and receptor-operated channels that function upon ligand binding [reviewed in [44] [45] [46] . Together, the coordinated actions of these external and internal channels cause a complex increase of intracellular Ca 2+ . The coupling of the Ca 2+ signal and the signal transduction responses seems to depend on the duration, amplitude and frequency of the local Ca 2+ concentration at a given place in the cell, at a given time. Initial findings implicated Ca 2+ influx in Ras activation which was proven upon discovery of Ca 2+ /calmodulin activation of Ras-GRF1 [47] [48] [49] . Importantly, recent data showed that Cdk5 activity is also regulated by Ca 2+ levels [43] . A glutaminergic-mediated calcium influx causes a calmodulin-dependent activation of Cdk5 which autophosphorylates p35, which is then ubiquitinated and targeted for degradation by the proteosome [50] . This Ca 2+ -dependent process also relies on an enzyme's ability to recognize levels of phosphorylated proteins such as RasGRF1 and p35. We also believe that phosphorylated RasGRF1 levels cross a threshold and is then recognized by m-calpain and degraded. Similarly, phosphorylated p35 crosses a threshold where an ubiquitin ligase attaches ubiquitin and then directs p35 to the proteasome for degradation. The tight regulation of Ca 2+ levels which mediate RasGRF1 activation and Cdk5 activity, control levels of Ras activity which is critical for normal neuronal organization and function.
In this report, we have uncovered a novel pathway of regulation of RasGRF1 steady state levels through phos- and internal stores such as endoplasmic reticulum (ER) and binds to calmodulin (1). Ca 2+ -calmodulin then binds to RasGRF1 to facilitate its activation (2) . Upon activation, RasGRF1 facilitates the conversion of inactive Ras (Ras-GDP) to its active form (Ras-GTP) with downstream signaling and cellular effects (3). When Ras activation needs to be reduced, Cdk5, when associated with its activator p35, phosphorylates RasGRF1 on serine 731 (4). The phosphorylated form is then recognized by m-calpain whose activity is also controlled by local Ca 2+ concentrations (5) . When Ras activation needs to be increased, Ca 2+ -calmodulin causes p35 phosphorylation (in response to a glutaminergic-mediated calcium influx) which then targets the activator for ubiquitination and subsequent degradation by the proteosome. This will increase RasGRF1 levels and Ras activation.
phorylation by p35/Cdk5. We have shown that levels of RasGRF1 are critical in neuronal nuclear organization evident by both overexpression and reduction of Ras-GRF1. This report, with our previous findings, places Cdk5 in a central regulatory role, where phosphorylation of two distinct GEFs have different biological effects in neurons. The phosphorylation of RasGRF2 modulated MAP1b distribution while that of RasGRF1 controlled nuclear organization in neurons. Further investigation to identify neuronal factors important for neuronal organization needs to be carried out and would provide information about fundamental processes involved in nuclear integrity. The importance of the regulatory role Cdk5 plays in nervous system signal transduction cascades has been demonstrated and will be critical to our understanding in these processes.
